期刊文献+

抗心力衰竭治疗对慢性充血性心力衰竭病人血浆BNP及CA125的影响 被引量:8

下载PDF
导出
摘要 目的探讨慢性充血性心力衰竭病人治疗前后血浆脑利钠肽(BNP)及糖类抗原125(CA125)的变化。方法 30例慢性充血性心力衰竭病人接受常规抗心力衰竭治疗4周,检测治疗前后血浆BNP、CA125水平变化。结果治疗4周后,血浆BNP及CA125均较治疗前明显下降,治疗前血浆BNP及CA125呈正相关(P<0.05)。结论慢性充血性心力衰竭病人血浆BNP及CA125治疗前明显升高,治疗后明显下降;联合检测血浆BNP及CA125可作为诊断心力衰竭的筛选指标,并可用于指导心力衰竭的治疗,评价心力衰竭治疗的疗效。
作者 马京炬
出处 《中西医结合心脑血管病杂志》 2013年第2期225-226,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
  • 相关文献

参考文献8

二级参考文献11

  • 1邢云利 贾三庆.BNP可作为心衰诊断和预后的新指标[J].中国医学论坛报,2002,28:14-14. 被引量:5
  • 2刘承云.血清Ⅰ、Ⅲ型前胶原端肽浓度在心血管疾病中的意义[J].国外医学(心血管疾病分册),1997,24(4):18-20. 被引量:22
  • 3[1]Maeda K,Tsutamota T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J,1998,135 : 825-832. 被引量:1
  • 4[2]Maisel AS,Krishnaswamy P, Richards M, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med, 2002,347:161-167. 被引量:1
  • 5[3]Mcdonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet, 1998,351:9-13. 被引量:1
  • 6[5]Suzuki T, Yamaoki K, Nakajima O, et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels . Jpn Heart J, 2000,41: 205-214. 被引量:1
  • 7[6]Cowie MW.BNP: soon to become a routine measure in the care of patients with heart failure? Heart,2000,83:617-618. 被引量:1
  • 8[7]Harrison A, Morrison LK, Krishnaswamy P, et al. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Ann Emerg Med, 2002, 39: 131-138. 被引量:1
  • 9[8]Valli N, Gobinet A, Bordenave L. Review of 10 years of the clinical use of brain natriureric peptide in cardiology.J Lab Clin Med, 1999, 134:437-444. 被引量:1
  • 10沈元琼.高血压病患者与正常人血清Ⅲ型前胶原N-末端肽含量对比研究[J].中国现代医学杂志,1998,8(3):24-25. 被引量:10

共引文献24

同被引文献68

  • 1徐良俊.美托洛尔治疗慢性充血性心力衰竭的临床效果观察[J].求医问药(下半月),2013(5):289-290. 被引量:2
  • 2韦育林,李楚强,陈锡龙,刘英梅,罗年桑.黄芪注射液对充血性心力衰竭患者细胞因子和血管紧张素Ⅱ的影响[J].中国临床康复,2006,10(3):54-56. 被引量:16
  • 3胡军民.慢性心力衰竭患者血清CA125测定及其意义[J].检验医学,2007,22(4):389-389. 被引量:7
  • 4中华医学会心血管病学分会 中华心血管病杂志编辑委员会.心血管疾病防治指南与共识.中华心血管病杂志,2007,35(1):5-16. 被引量:3
  • 5Vizzardi E,D'Aloia A,Curnis A,et al.Carbohydrate antigen 125:a new biomarker in heart failure[J].Cardiol Rev,2013,21 (1):23-26. 被引量:1
  • 6Okutucu S,Oto A.Risk stratification in nonischemic dilated cardiomyopathy:current perspectives[J].Cardiology Journal,2010,17 (3):219-229. 被引量:1
  • 7Turk HM,Pekdemir H,Buyukberber S,et al.Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid[J].Tumour Biol,2003,24(4):172-175. 被引量:1
  • 8Serkan O,Hakan O,Recai A,et al.Carbohydrate antigen125 and N-terminal pro-brain natriuretic peptide levels:compared in heart failure prognostication[J].Texas Heart Institute,2012,39(1):30-35. 被引量:1
  • 9Saitoh S,Onogi F.Multiple endothelial injury in epicardial coronary artery induces down stream microvascular spasm as well as remodeling partly viathromboxane A2[J].J Am Coll Cardiol,2011,37(1):308-315. 被引量:1
  • 10Devaraj S,Kumaresan PR,Jialal I.C-Reactive Prote in Induces Release of Both Endothelial Microparticles and Circulating Endothelial Cells In Vitro and In Vivo:Further Evidence of Endothelial Dysfunction[J].Clin Chem,2011,57(12):1757-1761. 被引量:1

引证文献8

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部